Gary B. Gordon serves as Executive at Ayala Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Gary B. Gordon has executed 7 insider transactions totaling $97.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 19, 2023 involved selling 58,520 shares valued at $0.
Gary B. Gordon currently holds 58,520 shares of Ayala Pharmaceuticals, Inc. (AYLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gary B. Gordon has been a net seller of AYLA stock. They have purchased $0 and sold $97.5K worth of shares.
Gary B. Gordon's most recent insider trade was on Jan 19, 2023, when they sold 58,520 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 24, 2021 | AYLA | $15.5K | Option Exercise | 3,000 | $5.16 | Discretionary |
| Feb 24, 2021 | AYLA | $52.4K | Sale | 3,000 | $17.46 | Discretionary |
| Jan 20, 2021 | AYLA | $15.5K | Option Exercise | 3,000 | $5.16 | Discretionary |
| Jan 20, 2021 | AYLA | $45.1K | Sale | 3,000 | $15.03 | Discretionary |
| Jan 4, 2021 | AYLA | $0 | Award | 8,520 | $N/A | Discretionary |